Navigating the Complexities of SGLT-2 Inhibitor Therapy: Balancing Benefits and Risks for Type 2 Diabetes Management
Mahadev Khurana & Sahil Kumar · Asian Journal of Research and Reports in Endocrinology · 2024
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors have emerged as potent oral hypoglycemic drugs for managing type 2 diabetes, offering significant benefits such as improved cardiovascular and renal functions along with weight loss. However, their usage is accompanied by variou...
Open access
Research Article